|Ahead of print publication
Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway
Fei Wu, Zu-Quan Xiong, Shan-Hua Mao, Ji-Meng Hu, Jian-Qing Wang, Hao-Wen Jiang, Qiang Ding
Department of Urology, Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China
|Date of Submission||21-Nov-2016|
|Date of Decision||09-Jan-2017|
|Date of Acceptance||06-Feb-2017|
|Date of Web Publication||04-Apr-2017|
Department of Urology, Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China
Source of Support: None, Conflict of Interest: None
Emerging evidence indicates that aldosterone and mineralocorticoid receptors (MRs) are associated with the pathogenesis of erectile dysfunction. However, the molecular mechanisms remain largely unknown. In this study, freshly isolated penile corpus cavernosum tissue from rats was treated with aldosterone, with or without MRs inhibitors. Nuclear factor (NF)-kappa B (NF-κB) activity was evaluated by real-time quantitative PCR, luciferase assay, and immunoblot. The results demonstrated that mRNA levels of the NF-κB target genes, including inhibitor of NF-κB alpha (IκB-α), NF-κB1, tumor necrosis factor-alpha (TNF-α), and interleukin 6 (IL-6), were higher after aldosterone treatment. Accordingly, phosphorylation of p65/RelA, IκB-α, and inhibitor of NF-κB kinase-β was markedly increased by aldosterone. Furthermore, knockdown of MRs prevented activation of the NF-κB canonical pathway by aldosterone. Consistent with this finding, ectopic overexpression of MRs enhanced the transcriptional activation of NF-κB by aldosterone. More importantly, the MRs antagonist, spironolactone blocked aldosterone-mediated activation of the canonical NF-κB pathway. In conclusion, aldosterone has an inflammatory effect in the corpus cavernosum penis, inducing NF-κB activation via an MRs-dependent pathway, which may be prevented by selective MRs antagonists. These data reveal the possible role of aldosterone in erectile dysfunction as well as its potential as a novel pharmacologic target for treatment.
Keywords: aldosterone; erectile dysfunction; NF-κB; receptors
Article in PDF
|How to cite this URL:|
Wu F, Xiong ZQ, Mao SH, Hu JM, Wang JQ, Jiang HW, Ding Q. Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway. Asian J Androl [Epub ahead of print] [cited 2017 Dec 14]. Available from: http://www.ajandrology.com/preprintarticle.asp?id=203807
Fei Wu, Zu-Quan Xiong
These authors contributed equally to this work.
| Introduction|| |
Erectile dysfunction (ED) is a common sexual dysfunction, with estimating that it affects 22% of men over 40 years of age. The incidence of ED is associated with diabetes, hypertension, aging, depression, and being overweight. The Massachusetts Male Aging Study reported that 52% men between 40 and 70 years old were affected by ED of varying severity. Among men with chronic coronary artery disease, the incidence of ED was approximate 75%., Although the etiology of ED is yet to be fully clarified, multiple signaling networks have been implicated in ED, including the nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) pathway, generation of reactive oxygen species (ROS), renin/angiotensin system (RAS), RhoA/Rho-associated protein kinase pathway, and tumor necrosis factor-alpha (TNF-α) pathway.
Notably, the TNF-α pathway has direct effects on vascular function and plays a critical role in cardiovascular diseases (CVD) which shares several risk factors with ED. Accumulating evidence from clinical and experimental studies also suggested that TNF-α is implicated in ED. For example, elevated plasma TNF-α levels have been linked to ED. TNF-α infusion was found to impair the function of the corpora cavernosa in mice. Binding of TNF-α to TNFR1 stimulated the expression of nuclear factor (NF)-kappa B (NF-κB) target genes, which are important for inflammatory responses and cell survival. In the canonical NF-κB pathway, TNF-α induces linear ubiquitination of inhibitor of kappaB kinase-gamma (IKK-γ)/NEMO and phosphorylation of IKK-β, with subsequently phosphorylation of inhibitor of NF-κB alpha (IκB-α)., Phosphorylated IκB-α is ubiquitinated by beta-transducing repeat-containing protein (β-TRCP) and degraded by the 26S proteasome, resulting in releasing the p65 and p50 protein dimers for nuclear translocation.
The hormone aldosterone, which was discovered over 50 years ago, is responsible for maintaining the electrolyte balance by the regulation of Na+ and K+ in the distal tubules and collecting ducts of the kidney. A retrospective study reported a 29% increase in aldosterone levels between control and severe ED groups. In human penile corpus cavernosum tissue, aldosterone facilitated the noradrenaline-induced contraction in organ bath, but not NO-dependent relaxation. mRNA expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11βHSD2) and mineralocorticoid receptors (MRs), the receptor for aldosterone, have been proved to be existed in isolated human penile corpus cavernosum tissue. It has been reported that aldosterone activates the NF-κB pathway in principal cells of the cortical collecting duct. However, the role of aldosterone in the corpus cavernosum of ED patients remains elusive. In the present study, we report that aldosterone stimulates the NF-κB transcriptional activity in penile corpus cavernosum tissue through MRs-dependent pathway.
| Materials and Methods|| |
The study was conducted in accordance with ethical guidelines and was approved by the Ethics Committee of Huashan Hospital, Fudan University.
Isolated corpus cavernosa tissues analysis
All experimental procedures were performed in accordance with the national experimental animal science guide for the care and use of laboratory animals. Sexually mature male Wistar-Kyoto rats (500-600 g body weight) were obtained from the Experimental Animal Center of Fudan University (Shanghai, China). Prior to experiments, rats were housed in a room with controlled temperature (23 ± 1°C) and a 12 h light/12 h dark cycle. Access to water and food was ad libitum. Penis corpus cavernosum tissue was obtained from 16-week-old rats. After euthanasia, the penis of each rat was removed, and real-time PCR and immunoblot assays were performed, as described previously. In each experimental group, isolated corpus cavernosa tissues from three rats were pooled to minimize the individual variation. Briefly, the whole penis was placed in cold Krebs-Henseleit buffer (NaCl: 118.4 nmol l−1, KCl: 4.7 nmol l−1, CaCl2 : 2.5 nmol l−1, KH2 PO4 : 1.2 nmol l−1, NaHCO3 : 25 nmol l−1, glucose: 11.7 nmol l−1). Then, the tunica albuginea, corpus spongiosum, and the urethra were anatomically separated and discarded. Longitudinal strips of corpus cavernosum were isolated and pulverized into cubes of approximately 1 mm3, which were placed in organ-bath chambers at 37°C (Radnoti Glass Technology Inc., Monrovia, CA, USA), followed by the addition of 10 ml of Krebs-Henseleit solution More Details. The cubes were continuously bubbled with a mixture of 95% O2 and 5% CO2, and equilibrated for 30 min for further in vitro experiments. Three to four cubes were incubated in a single well, with or without the administration of aldosterone (10 nmol l−1 -10 μmol l−1, Sigma Chemical Co., St. Louis, MO, USA) or recombinant human TNF-alpha protein (rhTNF-α or TNF-α, 20 ng ml−1, R and D system, Minneapolis, MN, USA), for prespecified time periods (1 h, 2 h, 3 h, 4 h, 5 h, and 6 h). With respect to co-administration, aldosterone and spironolactone (Sigma Chemical Co., St. Louis, MO, USA) were simultaneously added to the medium before harvest.
Analysis of transcriptional activity by qRT-PCR
RNA was extracted using QIAGEN RN easy mini kit, according to manufacturer's instructions (Studio City, CA, USA). For each sample, 1 μg total RNA was reverse transcribed using the iScrip Reverse Transcription Supermix (1708841, Bio-Rad Laboratories, Richmond, CA, USA). The generated cDNA template was mixed with primers for IκB-α (Forward: 5'- TGAAGGACGAGGAGTACGAGC-3'; Reverse: 5'-TGCAGGAACGAGTCTCCGT-3'), NF-κB1 (Forward: 5'- ATGGCAGACGATGATCCCTAC-3'; Reverse: 5'-CGGAATCGAAATCCCCTCTGTT-3'), IL-6 (Forward: 5'- CTGCAAGAGACTTCCATCCAG-3'; Reverse: 5'-AGTGGTATAGACAGGTCTGTTGG -3'), TNF-α (Forward: 5'-CAGGCGGTGCCTATGTCTC-3'; Reverse: 5'- CGATCACCCCGAAGTTCAGTAG-3') and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Forward: 5'- AGGTCGGTGTGAACGGATTTG-3'; Reverse: 5'- GGGGTCGTTGATGGCAACA-3'), as well as PowerUp SYBR Green Master Mix (A25778, Applied Biosystems, Foster City, CA, USA), and the real-time RT-PCR reaction was conducted with the CFX96 Touc Real-Time PCR Detection System. Data quantitation was performed using the comparative CT (∆∆CT) method, with GAPDH gene expression as an endogenous reference.
In vitro assay in HMVECs
The human microvascular endothelial cells (HMVECs) were a generous gift from Wei Lab. The generation and identification of HMVECs were described in detail by Shao and Guo. Briefly, HMVECs were cultured in endothelial growth medium containing 2% bovine serum and 0.2% bovine brain extract. The cells were grown at 37°C with 5% CO2 and subcultured at 50%-80% confluence using 0.05% trypsin -0.02% Ethylenediaminetetraacetic acid (EDTA). Penile corpus cavernosum tissues and confluent HMVECs were treated with aldosterone (10−9 -10−7 mol l−1), which was dissolved in dimethylsulfoxide (DMSO; 10 nmol l−1), the vehicle control. In selected experiments, cells were co-incubated with spironolactone.
Ectopic overexpression and endogenous knockdown
A Flag/Myc-tagged MRs plasmid was purchased from OriGene Technologies (Rockville, MD, USA). Cells were transfected using Lipofectamine (Life Technologies, Gaithersburg, MD, USA) in OptiMEM medium, according to the manufacturer's instructions. At 48 h posttransfection, transfected cells were subjected to immunoblot analysis to detect the efficacy of transfection. Lentiviral short hairpin RNAs (shRNAs) for human NR3C2 were purchased from GE Dharmacon (Chicago, IL, USA).
The following are DNA oligonucleotide sequences for the NR3C2-directed shRNA No. 1 (antisense, 5'- TTGTCTT GCTGAAGGCAAG-3'), shRNA No. 2 (antisense, 5'- AAGGCAA AGTTCTTCTGGG-3'). Lentiviral shRNA constructs against green fluorescent protein (GFP) were a generous gift from Dr. Yang Sun (Department of Dermatology, Qilu Hospital, Shandong University, China).
Western blot analysis
Cells were lysed in EBC buffer (50 mmol l−1 Tris [pH 7.5], 120 mmol l−1 NaCl, 0.5% NP-40) supplemented with protease inhibitors and phosphatase inhibitors (phosphatase inhibitor cocktail set I and II, Calbiochem, La Jolla, CA, USA). Subcellular fractions of tissues were extracted by a Subcellular Proteome Extraction Kit (Merck Millipore, Darmstadt, Germany). Briefly, cells at 80% confluence in a 10-cm dish (5 × 106 -8 × 106 cells) were washed twice using cold phosphate-buffered saline solution (PBS) or wash buffer. The dish was overlaid with 1 ml of extraction buffer I, without disturbing cells. After incubation on ice for 10 min with gentle agitation, the supernatant was transferred to a clean tube as the cytoplasmic fraction. Remnant cellular material was added to 500 μl of extraction buffer III and incubated for 10 min at 4°C with gentle rotation. The samples were sonicated and centrifuged at 15 000 g for 10 min to obtain the supernatant as the nuclear fraction. Protein concentrations of the lysates were measured using the Bio-Rad protein assay reagent on a DU-800 UV/VIS spectrophotometer (Beckman Coulter, Brea, CA, USA). The lysates were then resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with the indicated antibodies. The detailed information of antibodies used in this study is listed in [Table 1]. The protocol for protein extraction and immunoblotting has been described in detail previously.
Luciferase assays were performed as described previously. Briefly, cells grown in 6-well plates were transfected with an NF-κB firefly luciferase reporter plasmid 3X-κB-Luc (a gift from Dr. Hiroyuki Inuzuka) and a firefly luciferase reporter containing the IL-6 promoter (a gift of Dr. Hiroyuki Inuzuka) along with a pRL-CMV plasmid (Promega, Madison, WI, USA). After 24 h, cells were split into 96-well plates. After stimulation with aldosterone, firefly luciferase activity was measured using the Dual Luciferase Assay System and normalized to renilla luciferase activity according to manufacturer's instructions (Promega, Madison, WI, USA).
Results are presented as mean standard deviation from at least three independent experiments. Comparison between two groups was performed by one-way analysis of variance (ANOVA). P < 0.05 was considered statistically significant.
| Results|| |
Activation of NF-κB transcription in freshly isolated corpus cavernosum
The freshly isolated penile corpus cavernosum tissues were treated with DMSO, aldosterone (1 μmol l−1) or TNF-α (20 ng ml−1) for 1 h in Krebs solution, without bovine serum or antibiotics. qRT-PCR was applied to detect mRNA expression of the specified genes: IκB-α, NF-κB1, IL-6, TNF-α, and GAPDH. As shown in [Figure 1]a-[Figure 1]d, relative mRNA expression of IκB-α, NF-κB1, IL-6, and TNF-α was increased after aldosterone or TNF-α treatment compared with DMSO as a negative control (P < 0.05). TNF-α was a well-recognized stimulator of the canonical NF-κB pathway and was used as a positive control. Although transcriptional activity of NF-κB by aldosterone was lower than that in the TNF-α group, the activating effect of aldosterone was statistically significant when compared with the negative control group (P < 0.05). The optimal aldosterone concentration for its activation effect was confirmed and evaluated by luciferase assay in HMVECs. After co-transfection of NF-κB firefly luciferase reporter plasmid 3X-κB-Luc and a firefly luciferase reporter, luciferase assays showed that NF-κB transcriptional activity peaked at 2-4 h after aldosterone treatment ([Figure 1]e). Concentration-dependent assays indicated that the optimal concentration of aldosterone for maximum activation was approximately 1-10 μmol l−1 ([Figure 1]f). In this study, 1 μmol l−1 was selected as the concentration to amplify and visualize the effects of aldosterone on the corpus cavernosum and HMVECs, although 1 μmol l−1 was hundreds of times higher than under physiological conditions.
|Figure 1: Aldosterone (Aldo) stimulates nuclear factor (NF)-kappa B transcriptional activity in freshly isolated corpus cavernosum from rats. Relative mRNA levels of (a) inhibitor of NF-κB alpha (IκB-α), (b) NF-κB1, (c) interleukin 6 (IL-6), and (d) TNF-α were increased after aldosterone or tumor necrosis factor-alpha (TNF-α, 20 ng ml−1) treatment compared with dimethylsulfoxide as a negative vehicle control. (e) Luciferase assays showed that maximum transcriptional activity of NF-κB occurred at 1-4 h after aldosterone treatment in human microvascular endothelial cells. (f) Concentration-dependent assays indicated that the optimal concentration of aldosterone for maximum effect was approximately 1 µmol l−1. DMSO: dimethylsulfoxide. Data are presented as the mean ± standard deviation (n = 3). *P < 0.05, **P < 0.01 (one-way analysis of variance).|
Click here to view
The canonical NF-κB pathway is activated by aldosterone
Protein readouts of NF-κB activation in the freshly isolated penile corpus cavernosum tissues were detected by immunoblot ([Figure 2]a). Phosphorylation of p65/RelA was increased at 1h and 2 h after aldosterone stimulation. Concordant with this finding, IκB-α was phosphorylated at 1 h, with a marked decline from 1 h to 4 h, indicating that the NF-κB signaling pathway was active during this time. Phosphorylation of IKK-α/β was also altered by aldosterone treatment. Of importance, p100 and p52, which were key factors in the noncanonical NF-κB pathway, were not affected by aldosterone ([Figure 2]a). Consequently, phosphorylated p65/RelA could undergo nuclear translocation and bind to the promotors of target genes. These molecular changes were also visualized in protein subcellular fractions analyzed by immunoblot ([Figure 2]b). In the nuclear fraction of isolated penile corpus cavernosum tissues, p65 protein was increased in the experimental groups compared with DMSO treatment, demonstrating that both TNF-α (20 ng ml−1) and aldosterone (1 μmol l−1) induced the nuclear translocation of p65. Consistent with this finding, in the cytosolic fraction, phosphorylation of IκB-α increased dramatically and subsequently declined after aldosterone and TNF-α treatment ( [Figure 2]b).
|Figure 2: The canonical nuclear factor (NF)-kappa B pathway is activated after aldosterone (Aldo) treatment. (a) Protein markers of NF-κB activation were detected by immunoblot analysis of freshly isolated penile corpus cavernosum tissues. (b) In the nuclear fraction of isolated penile corpus cavernosum tissues, p65 protein was increased in the experimental groups compared with dimethylsulfoxide vehicle control. In the cytosolic fraction, phosphorylation of inhibitor of NF-κB alpha (IκB-α) displayed a sharp increase and subsequently declined after aldosterone or tumor necrosis factor-alpha (TNF-α, 20 ng ml−1) treatment. DMSO: dimethylsulfoxide; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.|
Click here to view
The activation of NF-κB signaling pathway is MRs dependent
To determine whether the activation of NF-κB signaling by aldosterone was MR dependent, experiments on the isolated penile corpus cavernosum were conducted with an MR antagonist, spironolactone. Compared with aldosterone stimulation, the combination of aldosterone and spironolactone restored the relative mRNA transcription of NF-κB target genes, including IκB-α, NF-κB1, IL-6, and TNF-α ([Figure 3]a-[Figure 3]d). Interestingly, spironolactone treatment (0.5 μmol l−1 for 1 h) was sufficient to reverse the activating effect of aldosterone (1 μmol l−1) on NF-κB transcriptional activity. The optimal concentration of spironolactone was further confirmed by luciferase assays in a concentration-dependent manner in HMVECs. Notably, 0.5 μmol l−1 was the least effective concentration to prevent the activation effect of aldosterone ([Figure 3]e). In HMVEC cells, a gain-of-function assay was performed by ectopic overexpression of a Flag/Myc-tagged MR protein. In MR-overexpressing cells, the transcriptional activation effect of aldosterone was amplified, based on luciferase assays ([Figure 3]f). To further confirm this mechanism at an endogenous level, shRNAs targeting the MR-encoding gene, nuclear receptor subfamily 3 group C member 2 ( NR3C2), were packaged into a lentivirus to construct stable cell lines with MR knockdown. As shown in [Figure 3]g, approximately 80% of endogenous MRs were knocked down by the shRNA. In cell lines with stable MR knockdown, aldosterone failed to activate the transcriptional activity of the NF-κB complex, according to luciferase assays ([Figure 3]h).
|Figure 3: Activation of nuclear factor (NF)-kappa B signaling pathway was mineralocorticoid receptors (MRs) dependent. Co-administration of aldosterone (Aldo) and spironolactone (Spiro) in human microvascular endothelial cells prevented the increase in relative mRNA levels of NF-κB target genes, including (a) inhibitor of NF-κB alpha (IκB-α), (b) NF-κB1, (c) interleukin 6 (IL-6) and (d) tumor necrosis factor-alpha (TNF-α). (e) Luciferase assays conducted in a concentration-dependent manner in HMVECs. 0.5 µmol l−1 of spironolactone was the least effective concentration to prevent the activation effect of aldosterone. (f) The transcriptional activation effect of aldosterone was augmented, based on luciferase assays, when MRs were ectopically overexpressed in HMVECs. (g) Approximately 80% of endogenous MRs were knocked down by shRNA transfection in HMVECs. (h) In stable MR-knockdown HMVEC lines, aldosterone failed to activate the transcriptional activity of NF-κB, according to luciferase assays. Data are presented as the mean ± standard deviation (n = 3). *P < 0.05, **P < 0.01 (one-way analysis of variance). EV: empty vector; HMVECs: human microvascular endothelial cells; DMSO: dimethylsulfoxide; NR3C2: mineralocorticoid receptor/nuclear receptor subfamily 3, group C2; GFP: green fluorescent protein.|
Click here to view
Spironolactone reverses the activation of NF-κB by aldosterone
To gain further insight into whether the MR-dependent effect of aldosterone was consistent in freshly isolated penile corpus cavernosum tissues, prevention of NF-κB transcriptional activation was examined by immunoblotting in a time course manner. Compared with previous assays using aldosterone treatment ([Figure 2]a), phosphorylation of p65 and IκB-α was delayed, and sharply attenuated, when spironolactone (0.5 μmol l−1) and aldosterone (1 μmol l−1) were added at the same time for indicated hours ([Figure 4]a). In isolated penile corpus cavernosum tissues, the time course of relative mRNA expression of NF-κB target genes was investigated to illustrate the dynamic effect of aldosterone and spironolactone on NF-κB signaling. As shown in [Figure 4]b, the increase in IκB-α mRNA induced by aldosterone was partially inhibited by spironolactone. Accordingly, spironolactone prevented the transcriptional activation of TNF-α ([Figure 4]c). Thus, in penile corpus cavernosum tissues, aldosterone activated NF-κB signaling, which was prevented by an MR antagonist, spironolactone. In both freshly isolated corpus cavernosum tissues and cultured HMVECs, NF-κB signaling was activated by aldosterone in an MR-dependent manner.
|Figure 4: Reversion of aldosterone (Aldo)-induced nuclear factor (NF)-kappa B activation. (a) Phosphorylation of p65 and inhibitor of NF-κB alpha (IκB-α) was attenuated by co-administration of spironolactone (Spiro, 0.5 µmol l−1) and aldosterone (1 µmol l−1) in freshly isolated penile corpus cavernosum tissues. (b) Time courses obtained from quantitative real-time polymerase chain reaction showed that the aldosterone-mediated increase in IκB-α mRNA expression was dramatically inhibited by spironolactone in freshly isolated penile corpus cavernosum tissues. (c) Spironolactone prevented the aldosterone-mediated increase in tumor necrosis factor-alpha mRNA expression in freshly isolated penile corpus cavernosum tissues.|
Click here to view
| Discussion|| |
This study aimed to explore the mechanism of aldosterone in isolated penile corpus cavernosum tissues from rats. As a novel finding, the experiments showed that aldosterone activates transcriptional activity of the canonical NF-κB pathway in an MR-dependent manner in penile corpus cavernosum tissue and HMVECs. Specifically, transcription of NF-κB target genes, including IκB-α, NF-κB1, TNF-α, and IL-6, was enhanced by aldosterone treatment. Accordingly, phosphorylation of p65, IκB-α, and IKK-β was also markedly increased. Furthermore, knockdown of MRs by lenti-NR3C2-shRNA prevented aldosterone-mediated activation of the canonical NF-κB pathway. In line with these findings, ectopic overexpression of MRs enhanced the transcriptional activation of NF-κB by aldosterone. More importantly, spironolactone inhibited the canonical NF-κB pathway activation induced by aldosterone.
Two signaling pathways are involved in the functional NF-κB activity, the canonical and noncanonical pathways (also known as the classical and alternative pathways, respectively). Noncanonical NF-κB signaling, which is stimulated by CD40, lymphotoxin-β receptor, or B-cell activating factor receptor, contributes to lymphoid organogenesis, B-cell maturation and osteoclast differentiation. A critical signaling component of the noncanonical NF-κB pathway is the phosphorylation of IKKα, which induces phosphorylation-dependent ubiquitination and processing of p100. In this study, immunoblotting of protein markers of the canonical pathway indicated that aldosterone elicited the canonical, but not noncanonical NF-κB signaling, in an MRs-dependent manner. Notably, canonical NF-κB signaling stimulated the production of inflammatory cytokines, such as TNF-α and IL-6, which promoted chemotaxis and differentiation of lymphocytes, causing pathogenic effects over time. In relation to its influence on vascular disease, aldosterone was hypothesized to induce similar pathogenic effects in penile corpus cavernosum, including stress from reactive oxygen species, tissue remodeling, extracellular matrix degradation, and a self-perpetuating cycle of endothelial dysfunction and inflammation. Here, HMVECs, derived from vascular endothelial cells, were selected for in vitro experiments due to the shared features and risk factors between ED and cardiovascular disease, which prompted initial evaluation of NF-κB signaling at an endothelial level.
Importantly, an MR antagonist failed to completely reverse NF-κB activation by aldosterone. This may be explained by the MR-independent actions of aldosterone, in particular, direct activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which causes oxidative stress in endothelial cells, the heart or macrophages., As a result, reactive oxygen species generated as a byproduct of aldosterone activity may promote the NF-κB signaling pathway. However, based on data from this study, the MR-independent action of aldosterone on NF-κB signaling is not the dominant effect compared with the MR-dependent pathway. Therefore, MR antagonists may have potential to ameliorate injury to the penile corpus cavernosum tissues caused by aldosterone-MR-NF-κB pathway activation.
Taken together, the study results demonstrated that aldosterone activated the canonical NF-κB pathway in penile corpus cavernosum tissues and HMVECs in an MR-dependent manner. Increased expression of MRs led to elevation of NF-κB transcriptional activity induced by aldosterone, while MR knockdown prevented the activation. The MR antagonist spironolactone markedly suppressed activation of NF-κB signaling by aldosterone. These data may reveal a potential pharmacologic target for the treatment of ED.
| Author Contributions|| |
FW, ZQX, and SHM performed the experiments, elaborated and analyzed the data. HWJ and QD analyzed and discussed the data. JMH and JQW contributed to the discussion of results. FW and ZQX designed the study, analyzed and discussed the results, and wrote the paper. All authors read and approved the final manuscript.
| Competing Interests|| |
All authors declare no competing interests.
| Acknowledgments|| |
This work was supported by the National Basic Research Program of China (2015CB943003) and the National Natural Science Foundation of China (81370753). Dr. Fei Wu received financial support from the China Scholarship Council (CSC 201506100054). We thank Dr. Yang Sun (Department of Dermatology, Qilu Hospital, Shandong University, China) for proofreading of our manuscript and all her supports.
| References|| |
Laumann EO, West S, Glasser D, Carson C, Rosen R, et al.
Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med
2007; 4: 57-65.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol
1994; 151: 54-61.
Kloner RA, Mullin SH, Shook T, Matthews R, Mayeda G, et al.
Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol
2003; 170: S46-50.
Son YJ, Jang M, Jun EY. Prevalence of erectile dysfunction and associated factors in Korean older adults with coronary artery disease. J Gerontol Nurs
2016; 42: 32-41.
Matsui H, Sopko NA, Hannan JL, Bivalacqua TJ. Pathophysiology of erectile dysfunction. Curr Drug Targets
2015; 16: 411-9.
Carneiro FS, Webb RC, Tostes RC. Emerging role for TNF-alpha in erectile dysfunction. J Sex Med
2010; 7: 3823-34.
Matos G, Hirotsu C, Alvarenga TA, Cintra F, Bittencourt L, et al.
The association between TNF-alpha and erectile dysfunction complaints. Andrology
2013; 1: 872-8.
Carneiro FS, Zemse S, Giachini FR, Carneiro ZN, Lima VV, et al.
TNF-alpha infusion impairs corpora cavernosa reactivity. J Sex Med
2009; 6 Suppl 3: 311-9.
Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol
2016; 12: 49-62.
Israel A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol
2010; 2: a000158.
Tokunaga F. Linear ubiquitination-mediated NF-κB regulation and its related disorders. J Biochem
2013; 154: 313-23.
Kanarek N, Ben-Neriah Y. Regulation of NF-κB by ubiquitination and degradation of the IκBs. Immunol Rev
2012; 246: 77-94.
Porter GA, Bogoroch R, Edelman IS. On the mechanism of action of aldosterone on sodium transport: the role of RNA synthesis. Proc Natl Acad Sci U S A
1964; 52: 1326-33.
Wu F, Mao S, Yu T, Jiang H, Ding Q, et al.
Elevated plasma aldosterone is an independent risk factor for erectile dysfunction in men. World J Urol
2016; 34: 999-1007.
Muguruma H, Kawanishi Y, Sugiyama H, Kagawa J, Tanimoto S, et al.
Effect of aldosterone on isolated human penile corpus cavernosum tissue. BJU Int
2008; 102: 500-3.
Kishimoto T, Fukawa T, Yamaguchi K, Yamamoto Y, Nakatsuji H, et al.
Mineralocorticoid receptor expression in human penile corpus cavernosum. J Med Invest
2013; 60: 21-6.
Chen R, Wang T, Rao K, Yang J, Zhang S, et al.
Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J Sex Med
2011; 8: 2773-80.
Shaik S, Nucera C, Inuzuka H, Gao D, Garnaas M, et al.
SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J Exp Med
2012; 209: 1289-307.
Shao R, Guo X. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro
angiogenesis. Biochem Biophys Res Commun
2004; 321: 788-94.
Wu F, Zhao ZH, Ding ST, Wu HH, Lu JJ. High mobility group box 1 protein is methylated and transported to cytoplasm in clear cell renal cell carcinoma. Asian Pac J Cancer Prev
2013; 14: 5789-95.
Fukushima H, Matsumoto A, Inuzuka H, Zhai B, Lau AW, et al.
SCF (Fbw7) modulates the NFκB signaling pathway by targeting NFκB2 for ubiquitination and destruction. Cell Rep
2012; 1: 434-43.
Cildir G, Low KC, Tergaonkar V. Noncanonical NF-κB signaling in health and disease. Trends Mol Med
2016; 22: 414-29.
Sun SC. The noncanonical NF-κB pathway. Immunol Rev
2012; 246: 125-40.
Ridker PM, Luscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J
2014; 35: 1782-91.
Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov
2002; 1: 621-36.
Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, et al.
Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology
2008; 149: 1009-14.
Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, et al.
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation
2004; 109: 2213-20.
Siomek A. NF-κB signaling pathway and free radical impact. Acta Biochim Pol
2012; 59: 323-31.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]